Cambium Biomaterials, Inc.
El Segundo, US · Founded 2019 · Delaware corporation · 1 known investors
Founders & leadership
SH
Stephan HerreraExecutive
SW
Simon WaddingtonExecutive
JG
James GriffinExecutive
NM
Nic MadrenExecutive
AG
ANDREW GUENTHNERExecutive
TG
Tim GardnerNamed on SEC filing
Board
FG
CP
Christopher PedersonBoard director
BS
Brett SchneiderBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$119.7M disclosed across 3 rounds · 2021–2025
▶$94.4MraisedDec 2025 · 33 investors · Other TechnologyRule 506(b)
▶$94.4MraisedDec 2025 · 33 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Christopher PedersonDirector
- Brett SchneiderDirector
- Francisco GimenezDirector
- Tim GardnerExecutive Officer
- Stephan HerreraExecutive Officer
- Simon WaddingtonExecutive Officer, Director
- James GriffinExecutive Officer
- Nic MadrenExecutive Officer
- Offering amount
- $101.4M
- Amount sold
- $94.4M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17.4MraisedNov 2023 · 16 investors · Other TechnologyRule 506(b)
▶$17.4MraisedNov 2023 · 16 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Eliot PenceExecutive Officer
- Stephan HerreraExecutive Officer
- Simon WaddingtonExecutive Officer, Director
- Francisco GimenezDirector
- Offering amount
- $20M
- Amount sold
- $17.4M
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$8MraisedSep 2021 · 3 investors · Other TechnologyRule 506(b)
▶$8MraisedSep 2021 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- ANDREW GUENTHNERExecutive Officer
- FRANCISCO GIMENEZDirector
- STEPHAN HERRERAExecutive Officer, Director
- SIMON WADDINGTONExecutive Officer, Director
- Offering amount
- $28M
- Amount sold
- $8M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Cambium Biomaterials, Inc.'s investors?
- Cambium Biomaterials, Inc.'s investors include 8VC.
- How much funding has Cambium Biomaterials, Inc. raised?
- Cambium Biomaterials, Inc. has disclosed $119.7M raised across 3 rounds.
- Where is Cambium Biomaterials, Inc. headquartered?
- Cambium Biomaterials, Inc. is headquartered in El Segundo, US.